Ian ReynoldsinRCSI DiscoverUsing proteomics to predict clinical high-risk patient outcomesProteomics can predict the development of psychotic disorders for patients in the clinical high-risk stateSep 4, 2020Sep 4, 2020
Ian ReynoldsinRCSI DiscoverNovel mechanisms of inflammatory signalling in cystic fibrosisRCSI research illustrates how inflammatory signalling in cystic fibrosis can be mediated by an increase in extracellular vesicles.Aug 14, 2020Aug 14, 2020
Ian ReynoldsinRCSI DiscoverInhibiting miRNAs as a new therapeutic strategy for cystic fibrosisSelective inhibition of miRNAs: An effective therapeutic strategy for improving CFTR dysfunctionJul 16, 2020Jul 16, 2020
Ian ReynoldsinRCSI DiscoverPredicting progression to dementia using blood-based microRNA: A chance for early intervention?Alzheimer’s Disease (AD) is the most common cause of dementia worldwide, with approximately 46 million people affected and a predicted…May 29, 2020May 29, 2020
Ian ReynoldsinRCSI DiscoverAn insight into the mechanisms of pulmonary toxicity from vapingAn increased number of pulmonary injury cases following the use of e-cigarette/vaping products have been reported by the US Centers for…Apr 17, 2020Apr 17, 2020
Ian ReynoldsinRCSI DiscoverA novel method of obtaining biodegradable polypeptide nanoparticlesBiodegradable nanoparticles play a key role as viable carries in many pharmaceutical and personal care products.Mar 5, 2020Mar 5, 2020
Ian ReynoldsinRCSI DiscoverUnderstanding mucin pool formation after chemoradiotherapyUnderstanding the role of mucin pool formation after patients with rectal cancer undergo chemoradiotherapyFeb 4, 2020Feb 4, 2020
Ian ReynoldsinRCSI DiscoverA New Treatment for Osteomyelitis?A potential new treatment for Osteomyelitis: Incorporating copper-eluting bioactive glass with collagen scaffolds.Feb 4, 2020Feb 4, 2020
Ian ReynoldsinRCSI DiscoverTreating inflammation and pulmonary exacerbations in cystic fibrosis patientsTargeting prophylactic agents in cystic fibrosis patients: the pathway to treating inflammation and pulmonary exacerbations?Feb 4, 2020Feb 4, 2020
Ian ReynoldsinRCSI DiscoverBET Inhibition: An effective therapeutic strategy for lobular breast cancer?Invasive lobular carcinoma (ILC) is a subtype of breast cancer that arises from the milk-producing lobules of the breast. It accounts for…Feb 4, 2020Feb 4, 2020
